Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000200406-13-000057
Filing Date
2013-05-03
Accepted
2013-05-03 16:03:53
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a1q10q3-31x13.htm 10-Q 1085966
2 EXHIBIT 31.1 CEO a201310-q1qexhibit311ceoce.htm EX-31.1 9508
3 EXHIBIT 31.1 CFO a201310-q1qexhibit311cfoce.htm EX-31.1 9910
4 EXHIBIT 32.1 CEO a201310-q1qexhibit321ceoce.htm EX-32.1 11415
5 EXHIBIT 32.1 CFO a201310-q1qexhibit321cfoce.htm EX-32.1 11860
12 jnjlogoa03.jpg GRAPHIC 4649
  Complete submission text file 0000200406-13-000057.txt   8845271

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jnj-20130331.xml EX-101.INS 1454784
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20130331.xsd EX-101.SCH 54692
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnj-20130331_cal.xml EX-101.CAL 106773
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20130331_def.xml EX-101.DEF 361133
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20130331_lab.xml EX-101.LAB 774477
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20130331_pre.xml EX-101.PRE 443340
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1212
Type: 10-Q | Act: 34 | File No.: 001-03215 | Film No.: 13812638
SIC: 2834 Pharmaceutical Preparations